{"disease":{"id":"cd7-acute-leukemia","name":"cd7 acute leukemia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04599556","title":"Clinical Trial for the Safety and Efficacy of Anti-CD7 CAR-T Cell Therapy for Patients With Relapsed or Refractory CD7 Positive Hematological Malignancy","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":81,"lead_sponsor_name":"Zhejiang University","has_results":false},{"nct_id":"NCT07008872","title":"CD7 CAR-T Cell Therapy Targeting CD7-positive Relapsed/Refractory T Cell Lymphoma/Acute Leukemia","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":40,"lead_sponsor_name":"Qi deng","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}